Home > Healthcare > Encephalitis Treatment Market > Table of Contents

Encephalitis Treatment Market - By Disease Type (Primary, Secondary), By Treatment (Antiviral, Steroid, Antibiotic, Immunoglobulin, Plasmapheresis), By Route of Administration (Oral, Parenteral), By End-user (Hospital), Global Forecast 2023 - 2032

  • Report ID: GMI5756
  • Published Date: May 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market definitions

1.2    Base estimates and calculations

1.3    Forecast calculations

1.4    Data sources

1.4.1    Secondary

1.4.1.1   Paid sources

1.4.1.2   Public sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1   Encephalitis treatment industry 3600 synopsis, 2018 – 2032 (USD Billion)

2.1.1    Business trends

2.1.2    Region trends

2.1.3    Disease type trends

2.1.4    Treatment trends

2.1.5    Route of administration

2.1.6    End-user trends

Chapter 3   Encephalitis Market Insights

3.1    Industry landscape, 2018 – 2032 (USD Billion)

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising prevalence of encephalitis

3.2.1.2    Increase in awareness about treatment for encephalitis

3.2.1.3    Increasing investment in R&D by pharmaceutical companies

3.2.1.4    Increase in government initiatives for encephalitis disease diagnosis and treatment

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost associated with the treatment

3.3    Growth potential analysis

3.3.1    By disease type

3.3.2    By treatment

3.3.3    By route of administration

3.3.4    By end-user

3.4    COVID-19 impact analysis

3.5    Clinical trial analysis

3.6    Regulatory landscape

3.7    Porter’s analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Global company market share analysis, 2022

4.4    Competitive positioning matrix, 2022

4.5    Strategic dashboard, 2022

Chapter 5   Encephalitis Treatment Market Estimates and Forecast, By Disease Type (USD Billion)

5.1    Key trends, by disease type

5.2    Primary encephalitis

5.3    Secondary encephalitis

Chapter 6   Encephalitis Treatment Market Estimates and Forecast, By Treatment (USD Billion)

6.1   Key trends, by treatment

6.2   Antiviral agents

6.3   Steroid injections

6.4   Antibiotics

6.5   Immunoglobulin therapy

6.6   Plasmapheresis

6.7   Other treatments

Chapter 7   Encephalitis Treatment Market Estimates and Forecast, By Route of Administration (USD Billion)

7.1   Key trends, by route of administration

7.2   Oral

7.3   Parenteral

7.4   Other routes of administration

Chapter 8   Encephalitis Treatment Market Estimates and Forecast, By End-user (USD Billion)

8.1   Key trends, by end-user

8.2   Hospitals

8.3   Specialty clinics

8.4   Other end-users

Chapter 9   Encephalitis Treatment Market Estimates and Forecast, By Region (USD Billion)

9.1   Key trends, by region

9.2   North America

9.2.1    U.S.

9.2.2    Canada

9.3   Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Switzerland

9.3.7    Rest of Europe

9.4   Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5   Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6   Middle East & Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    Rest of Middle East & Africa

Chapter 10   Company Profiles

10.1   Pfizer, Inc.

10.2   Merck & Co., Inc.

10.3   Allergan

10.4   GlaxoSmithKline plc

10.5   Abbott Laboratories

10.6   F. Hoffmann-La Roche Ltd.

10.7   Sanofi

10.8   Teva Pharmaceutical Industries Ltd.

10.9   Basilea Pharmaceutical Ltd.

10.10   Melinta Therapeutics LLC.

 

Authors: Mariam Faizullabhoy , Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 282
  • Countries covered: 21
  • Pages: 160
 Download PDF